Secondary Prevention

"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The prevention of recurrences or exacerbations of a disease or complications of its therapy.

Descriptor ID	D055502
MeSH Number(s)	E02.897 N02.421.726.825 N06.850.780.750
Concept/Terms	Secondary Prevention Secondary Prevention Prevention, Secondary Preventions, Secondary Secondary Preventions Secondary Disease Prevention Disease Prevention, Secondary Disease Preventions, Secondary Prevention, Secondary Disease Preventions, Secondary Disease Secondary Disease Preventions Relapse Prevention Relapse Prevention Prevention, Relapse Preventions, Relapse Relapse Preventions Early Therapy Early Therapy Early Therapies Therapies, Early Therapy, Early

Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Secondary Prevention [E02.897]
Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Secondary Prevention [N02.421.726.825]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Secondary Prevention [N06.850.780.750]

Below are MeSH descriptors whose meaning is related to "Secondary Prevention".

Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.

Bar chart showing 181 publications over 25 distinct years, with a maximum of 15 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
1999	0	2	2
2000	0	2	2
2001	0	2	2
2002	0	6	6
2003	0	5	5
2004	0	2	2
2005	0	5	5
2006	0	5	5
2007	0	9	9
2008	1	12	13
2009	0	10	10
2010	1	14	15
2011	3	5	8
2012	1	11	12
2013	5	9	14
2014	0	12	12
2015	4	6	10
2016	2	8	10
2017	4	6	10
2018	3	6	9
2019	2	6	8
2020	2	5	7
2021	1	2	3
2022	0	1	1

Below are the most recent publications written about "Secondary Prevention" by people in Profiles.

McGurgan IJ, Kelly PJ, Turan TN, Rothwell PM. Long-Term Secondary Prevention: Management of Blood Pressure After a Transient Ischemic Attack or Stroke. Stroke. 2022 04; 53(4):1085-1103.

View in: PubMed
de Havenon A, Sheth KN, Madsen TE, Johnston KC, Turan TN, Toyoda K, Elm JJ, Wardlaw JM, Johnston SC, Williams OA, Shoamanesh A, Lansberg MG. Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities. Stroke. 2021 10; 52(10):e635-e645.

View in: PubMed
Wabnitz AM, Chandler J, Treiber F, Sen S, Jenkins C, Newman JC, Mueller M, Tinker A, Flynn A, Tagge R, Ovbiagele B. Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk factor: Protocol of a RCT. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105815.

View in: PubMed
Jones WS, Mulder H, Wruck LM, Pencina MJ, Kripalani S, Muñoz D, Crenshaw DL, Effron MB, Re RN, Gupta K, Anderson RD, Pepine CJ, Handberg EM, Manning BR, Jain SK, Girotra S, Riley D, DeWalt DA, Whittle J, Goldberg YH, Roger VL, Hess R, Benziger CP, Farrehi P, Zhou L, Ford DE, Haynes K, VanWormer JJ, Knowlton KU, Kraschnewski JL, Polonsky TS, Fintel DJ, Ahmad FS, McClay JC, Campbell JR, Bell DS, Fonarow GC, Bradley SM, Paranjape A, Roe MT, Robertson HR, Curtis LH, Sharlow AG, Berdan LG, Hammill BG, Harris DF, Qualls LG, Marquis-Gravel G, Modrow MF, Marcus GM, Carton TW, Nauman E, Waitman LR, Kho AN, Shenkman EA, McTigue KM, Kaushal R, Masoudi FA, Antman EM, Davidson DR, Edgley K, Merritt JG, Brown LS, Zemon DN, McCormick TE, Alikhaani JD, Gregoire KC, Rothman RL, Harrington RA, Hernandez AF. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.

View in: PubMed
Abdul Rahman L, Wabnitz AM, Turan TN. Secondary Stroke Prevention and Management for the Neuro-Ophthalmologist. J Neuroophthalmol. 2020 12; 40(4):463-471.

View in: PubMed
Zinzow H, Shi L, Rennert L, Chen L, Lopes S, Zhang L, Jones K, Jindal M, Stam C, Mclain M. Study protocol for a randomized controlled trial of mindfulness-based relapse prevention for opioid use disorders. Contemp Clin Trials. 2020 12; 99:106182.

View in: PubMed
Chalhoub RM, Kalivas PW. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Drugs. 2020 Oct; 80(15):1509-1524.

View in: PubMed
Payne JE, Badertscher P, Field ME, Sturdivant JL, Gold MR. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing. Circ Arrhythm Electrophysiol. 2020 09; 13(9):e008631.

View in: PubMed
Short NA, Morabito DM, Gilmore AK. Secondary prevention for posttraumatic stress and related symptoms among women whohave experienced a recent sexual assault: A systematic review and meta-analysis. Depress Anxiety. 2020 10; 37(10):1047-1059.

View in: PubMed
Marquis-Gravel G, Roe MT, Robertson HR, Harrington RA, Pencina MJ, Berdan LG, Hammill BG, Faulkner M, Muñoz D, Fonarow GC, Nallamothu BK, Fintel DJ, Ford DE, Zhou L, Daugherty SE, Nauman E, Kraschnewski J, Ahmad FS, Benziger CP, Haynes K, Merritt JG, Metkus T, Kripalani S, Gupta K, Shah RC, McClay JC, Re RN, Geary C, Lampert BC, Bradley SM, Jain SK, Seifein H, Whittle J, Roger VL, Effron MB, Alvarado G, Goldberg YH, VanWormer JL, Girotra S, Farrehi P, McTigue KM, Rothman R, Hernandez AF, Jones WS. Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. JAMA Cardiol. 2020 05 01; 5(5):598-607.

View in: PubMed

People

Explore

Similar Concepts

Top Journals